Literature DB >> 2430572

Inhibition of angiogenesis by the antineoplastic agents mitoxantrone and bisantrene.

P J Polverini, R F Novak.   

Abstract

The effects of mitoxantrone and bisantrene on angiogenic responses induced by tumor cell-conditioned media in the avascular cornea of rat eye have been evaluated. Both mitoxantrone and bisantrene effectively inhibited, in a concentration-dependent manner, angiogenesis induced by conditioned media obtained from either a hamster buccal pouch carcinoma cell line or P388D1 murine macrophage-like cells. Whereas vessel ingrowth in corneas containing tumor cell-conditioned media was detected as early as day 2 or 3 and was maximal by day 7, inclusion of mitoxantrone or bisantrene in the conditioned media at a 1:1 ratio (160 microM mitoxantrone or 32 microM bisantrene) resulted in complete inhibition of angiogenesis throughout the 14-day evaluation period. When concentrations of 64 and 32 microM mitoxantrone or 13 and 6.4 microM bisantrene were employed there was a marked delay in the appearance of capillary blood vessels (day 5 to 7) and a reduction in the intensity of angiogenic responses. No untoward toxicity to the tissue was observed at the concentrations of mitoxantrone or bisantrene employed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430572     DOI: 10.1016/0006-291x(86)90720-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  D Faulds; J A Balfour; P Chrisp; H D Langtry
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

2.  Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme.

Authors:  Jochen Tuettenberg; Rainer Grobholz; Tobias Korn; Frederik Wenz; Ralf Erber; Peter Vajkoczy
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-28       Impact factor: 4.553

3.  Metronomic chemotherapy: changing the paradigm that more is better.

Authors:  O G Scharovsky; L E Mainetti; V R Rozados
Journal:  Curr Oncol       Date:  2009-03       Impact factor: 3.677

4.  Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.

Authors:  L Manso; N Valdiviezo; J Sepúlveda; E Ciruelos; C Mendiola; I Ghanem; E Vega; R Manneh; M Dorta; H Cortés-Funes
Journal:  Clin Transl Oncol       Date:  2012-12-21       Impact factor: 3.405

5.  AQ4, an antitumor anthracenedione, inhibits endothelial cell proliferation and vascular endothelial growth factor secretion: implications for the therapy of ocular neovascular disorders.

Authors:  Swita Raghava; Uday B Kompella
Journal:  Eur J Pharmacol       Date:  2007-05-06       Impact factor: 4.432

6.  Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors.

Authors:  Kuo-Ching Mei; Yu-Pei Liao; Jinhong Jiang; Michelle Chiang; Mercedeh Khazaieli; Xiangsheng Liu; Xiang Wang; Qi Liu; Chong Hyun Chang; Xiao Zhang; Juan Li; Ying Ji; Brenda Melano; Donatello Telesca; Tian Xia; Huan Meng; Andre E Nel
Journal:  ACS Nano       Date:  2020-09-25       Impact factor: 15.881

7.  Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis.

Authors:  Per Albertsson; Bo Lennernäs; Klas Norrby
Journal:  APMIS       Date:  2011-10-25       Impact factor: 3.205

8.  Serum molecular signature for proliferative diabetic retinopathy in Saudi patients with type 2 diabetes.

Authors:  Jianbo Pan; Sheng Liu; Michael Farkas; Mark Consugar; Donald J Zack; Igor Kozak; J Fernando Arevalo; Eric Pierce; Jiang Qian; Eman Al Kahtani
Journal:  Mol Vis       Date:  2016-06-11       Impact factor: 2.367

9.  In vitro effect of chlorambucil on human glioma cell lines (SF767 and U87-MG), and human microvascular endothelial cell (HMVEC) and endothelial progenitor cells (ECFCs), in the context of plasma chlorambucil concentrations in tumor-bearing dogs.

Authors:  Michael J Reese; Deborah W Knapp; Kimberly M Anderson; Julie A Mund; Jamie Case; David R Jones; Rebecca A Packer
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

10.  Characteristics of the inhibitory effect of mitoxantrone and pirarubicin on lung metastases of colon carcinoma 26.

Authors:  M Iigo; M Shimamura; K Sagawa; H Tsuda
Journal:  Jpn J Cancer Res       Date:  1995-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.